Yesterday in Manhattan, New York’s health tech scene took to the restaurant and performance space City Winery to see what the latest batch of Blueprint Health‘s accelerator participants have been up to for the last few months. The event was its fifth demo-day since its launch in 2012. The seven companies accepted into Blueprint’s accelerator program took to the stage to showcase what they’ve done.
Blueprint is a New York-based health tech network, so quite obviously all of the companies showcased today represented some facet of the healthcare umbrella. They kind of work the companies did, however, ranged.
The primary focus for each company, though, is its viability and ability to make money in a timely fashion. Blueprint as a program focuses on this heavily, and touts impressive past companies, including Artemis which says it’s on track to do $2 million in revenue and SpotMe, which has already exceeded 400,000 users. It also invited WellTrackOne — a recent Blueprint grad — to the stage to announce that it has raised a $1.5 million Series A and is on track to hit $2 million in revenue this year.
Thus it’s no surprise that each company exhibited ways it was already a successful venture. For example, ProofPilot — a platform to ease the planning and execution of research studies and clinical trial — announced to the audience that it is already on its way to making $1 million in revenue this year.
Similarly PulseBeat, which makes a series of monitors and other devices to be used in loved ones’ houses to make sure they are well without requiring constant supervision, announced similar growth. According to its founder, PulseBeat is already being used by over 1,000 patients, and is signing a distribution partnership with the largest nursing association in Orange County.
Other companies trumpeted similar benchmarks — the idea was that Blueprint’s three month program provided these green companies with invaluable tutelage that has them already making waves. And, of course, all of these upstarts were raising money — anywhere from $500,000 to $1.4 million.
With each presentation was the underlying message that New York rising to American tech dominance. Blueprint flaunts these graduates to show the kinds of viable businesses it, along with New York, can create.
Doug Hayes, the Blueprint’s director, told me that this is undoubtedly an indication that New York’s tech scene is booming, as is Blueprint’s impact. Its demand has been growing, now seeing an excess of 1,000 applications each year for its accelerator (which generally accepts around seven startups). This is both Blueprint doing something right as well as being in the right place. He said that all of the right kinds of people — entrepreneurs, investors, medical professionals — live here to make this kind of program thrive. “And we’re now getting the dev talent,” he added.
Earlier this week a report conducted by HR&A Advisors and funded by the Association for a Better New York, Google, Citi, and NY Tech Meetup was released trying to get at this exact point. In sum it was just a slew of data-points bolstering what Hayes said. For example, seven percent of New York’s workforce is now comprised of tech folks and that 45,000 new tech-related jobs have been added over the past 10 years. (Interestingly enough, another fact hidden in the lengthy report is that men outnumber women 7 to 3 when it comes to tech-related jobs.)
Reports like this is an example of those trying to move the New York tech needle now cheerfully announcing their impact, so too are events like the Blueprint Demo Day.
Here’s a list of the startups showcased:
[Photo: creating in the dark (Creative Commons)]